Public Policy Resources

Share

ACS CAN Supports Increased Research Funding in FY27

May 18, 2026

Increased investment at the National Institutes of Health (NIH), the National Cancer Institute (NCI), and level funding for Advanced Research Projects for Health (ARPA-H), in the fight against cancer year over year have been key to reducing the nation’s cancer mortality rate by 34% since 1991. To ensure that the research being supported today yields the cancer treatments of tomorrow, ACS CAN urges Congress to expand support in FY27 so that progress can continue.

PDF icon Download

Related Resources

May 22, 2025

ACS CAN Supports the Clinical Trial Modernization Act (H.R. 3521 / S. 4440)

The Clinical Trial Modernization Act (H.R. 3521 / S. 4440) increases access to clinical trials by allowing clinical trial sponsors to provide financial support to patients for costs associated with their trial participation, including medical cost-sharing like copays, and non-medical expenses such as travel, parking, food and lodging.

Read More

ACS CAN Comments on FDA Guidance on Integrating Randomized Controlled Trials into Routine Clinical Practice

December 15, 2024

ACS CAN submitted comments on draft U.S. Food and Drug Administration (FDA) guidance on Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice.

Read more